Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol., 28 July 2016
Sec. Experimental Pharmacology and Drug Discovery
Volume 7 - 2016 | https://doi.org/10.3389/fphar.2016.00226

Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn

Retracted

A retraction of this article was approved in:

  1. Retraction: Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn

    1. Read retraction
\r\nKislay RoyKislay RoyBhasker SriramojuBhasker SriramojuRupinder K. KanwarRupinder K. KanwarJagat R. Kanwar*Jagat R. Kanwar*
  • Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research, Centre for Molecular and Medical Research, School of Medicine, Faculty of Health, Deakin University, Geelong, VIC, Australia

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Roy K, Sriramoju B, Kanwar RK and Kanwar JR (2016) Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn. Front. Pharmacol. 7:226. doi: 10.3389/fphar.2016.00226

Received: 28 April 2016; Accepted: 13 July 2016;
Published: 28 July 2016; Retracted: 21 June 2017.

Edited by:

Benedetto Falsini, Catholic University of the Sacred Heart, Italy

Reviewed by:

Bashir M. Rezk, Southern University at New Orleans, USA
Rahul K. Keswani, University of Michigan, USA

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.